Kite Pharma, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Kite Pharma, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $94.00 million as of 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-08-10
- 2015-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $94.00M.
- 2015-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $73.10M.
- 2014-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $58.00M.
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $45.00M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2015-06-30 | $94.00M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $73.10M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $58.00M 10-Q · filed 2015-08-10 |
| 2014-09-30 | $45.00M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $35.90M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $15.40M 10-K · filed 2015-03-26 |